Carbyne Biometrics v. Apple: Fraud Prevention Patent Dispute Dismissed at Federal Circuit
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Carbyne Biometrics, LLC v. Apple, Inc. |
| Case Number | 25-2126 (Fed. Cir.) |
| Court | Federal Circuit |
| Duration | Sep 2025 – Mar 2026 174 days |
| Outcome | Dismissed — No Damages |
| Patents at Issue | |
| Accused Products | Apple’s authentication and transaction security infrastructure (e.g., Face ID, Touch ID) |
Case Overview
The Parties
⚖️ Plaintiff
Patent assertion entity focused on biometric authentication and fraud reduction technologies.
🛡️ Defendant
Global technology leader with a vast patent portfolio and significant investments in biometric security — most notably through Face ID, Touch ID, and its broader identity authentication ecosystem embedded across its device lineup.
Patents at Issue
This case centered on a key patent in the rapidly evolving biometric authentication and fraud prevention technology sectors. The patent covers methods for reducing fraud leveraging identity or behavioral signals.
- • US 10,713,656 B1 — Method, medium, and system for reducing fraud
Developing fraud prevention technology?
Check if your biometric or fraud-reduction method might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
The Federal Circuit dismissed the proceedings pursuant to Fed. R. App. P. 42(b) — the voluntary dismissal rule — upon stipulation of both parties. Each side was ordered to bear its own costs. No damages were awarded, no injunctive relief was granted, and no merits determination was issued by the court.
Key Legal Issues
The case was classified under “Invalidity/Cancellation Action,” strongly suggesting the central dispute involved challenges to the validity or patentability of U.S. Patent No. 10,713,656 B1. The voluntary dismissal, with each side bearing its own costs, is a neutral termination that neither confirms nor defeats the patent’s validity. However, the compressed timeline reflects a negotiated resolution that rendered the appeal moot, likely avoiding a full merits decision on patentability.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in biometric fraud prevention. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all 50+ related patents in this technology space
- See which companies are most active in biometric fraud prevention
- Understand implications for § 101 validity challenges
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Biometric authentication and fraud reduction method claims
50+ Related Patents
In biometric fraud prevention space
Design-Around Options
Challenges with abstract method claims
✅ Key Takeaways
Voluntary Federal Circuit dismissals under Rule 42(b) in invalidity actions often signal confidential licensing or covenant arrangements — monitor related prosecution and assertion activity.
Search related case law →The “Invalidity/Cancellation” verdict classification suggests PTAB proceedings may have preceded this appeal; practitioners should track the ‘656 patent’s inter partes review history at the USPTO.
Explore USPTO filings →Biometric and fraud-reduction method patents require ongoing FTO review as claim scope in this area remains unsettled.
Start FTO analysis for my product →Apple’s defense strategy demonstrates that systematic IPR filing and appellate readiness remains the most effective enterprise response to NPE assertions.
Try AI patent drafting →Frequently Asked Questions
U.S. Patent No. 10,713,656 B1 (Application No. US15/948744), covering a method, medium, and system for reducing fraud — a biometric fraud prevention technology.
The parties stipulated to voluntary dismissal under Fed. R. App. P. 42(b), with each side bearing its own costs. No merits determination on validity or infringement was issued.
While non-precedential, the case reinforces that validity challenges and appellate review create strong settlement leverage in NPE-asserted biometric method patent disputes.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- United States Court of Appeals for the Federal Circuit
- USPTO Patent Full-Text Database – US10713656B1
- Cornell Legal Information Institute — Fed. R. App. P. 42(b)
- PACER Case Locator
- PatSnap — AI-native platform for global innovation intelligence
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Product?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis.
Run FTO for My Product